Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
Feasibility of Switching Fluoropyrimidine Due to Cardiotoxicity Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Phase 1 Study of Pemigatinib in Patients With Advanced Malignancies With FGF/FGFR Alterations
- Status
- COMPLETED
- Phase
- PHASE1
Study of GNX102 in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Study of Safety, Pharmacokinetics, and Antitumor Activity of BGB-3245 in Participants With Advanced or Refractory Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Immune Resistance Interrogation Study
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Study of SYD985 With Niraparib in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161
- Status
- UNKNOWN
- Phase
- PHASE1
Study of NK Combined With Chemotherapy for Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- NA
Study of DC-CIK Combined With Chemotherapy for Advanced Solid Tumor
- Status
- UNKNOWN
- Phase
- NA
A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.
- Status
- TERMINATED
- Phase
- PHASE1
ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate SYD1875
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
BP1001-A in Patients With Advanced or Recurrent Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A MolEcularly Guided Anti-Cancer Drug Off-Label Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials
- Status
- COMPLETED
- Phase
- PHASE1
MAX-40279-01 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1